Laura Grau

Ms. Laura Grau


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
SCSeth A Creasy
Seth A Creasy
LWLiza Wayland
Liza Wayland
SPShelby L. Panter
Shelby L. Panter
SPSarah A. Purcell
Sarah A. Purcell
RRRebecca Rosenberg
Rebecca Rosenberg
VCVictoria A. Catenacci
Victoria A. Catenacci
The purpose of this study was to evaluate the feasibility and acceptability of randomizing adults with overweight and obesity (BMI 25–40 kg/m2) to morning (06:00–10:00) or evening (15:00–19:00) aerobic exercise. Participants completed four exercise sessions per week in the morning (AM, n = 18) or evening (PM, n = 15). The exercise program was 15 weeks and progressed from 70 to 80% heart rate maximum and 750–2000 kcal/week. Bodyweight, body composition, total daily energy expenditure (TDEE), energy intake (EI), sleep, sedentary behavior (SB), non-exercise physical activity (NEPA), and maximal aerobic capacity were assessed at baseline and week 15. Study retention was 94% and adherence to the supervised exercise program was ≥90% in both groups. Weight change was −0.9 ± 2.8 kg and −1.4 ± 2.3 kg in AM and PM, respectively. AM and PM increased TDEE (AM: 222 ± 399 kcal/day, PM: 90 ± 150 kcal/day). EI increased in AM (99 ± 198 kcal/day) and decreased in PM (−21 ± 156 kcal/day) across the intervention. It is feasible to randomize adults with overweight and obesity to morning or evening aerobic exercise with high levels of adherence. Future trials are needed to understand how the timing of exercise affects energy balance and body weight regulation.

1 May 2025 in Annals of Internal Medicine
Verified
Journal Article
Closed access
VCVictoria A. Catenacci
Victoria A. Catenacci
DODanielle Ostendorf
Danielle Ostendorf
ZPZhaoxing Pan
Zhaoxing Pan
LGLaura Grau
Laura Grau
SCSeth A Creasy
Seth A Creasy
EMEdward L. Melanson
Edward L. Melanson
Long-term (≥12 months) randomized trials evaluating the efficacy of intermittent fasting (IMF) as a dietary weight loss strategy are limited. Furthermore, no studies have compared IMF versus daily caloric restriction (DCR) when both interventions are provided in the context of a guidelines-based behavioral weight loss program. To compare the effects of 4:3 IMF versus DCR on changes in weight at 12 months, with comprehensive behavioral support provided to both groups. Randomized clinical trial. (ClinicalTrials.gov: NCT03411356). Denver, Colorado, and surrounding metropolitan area. Adults aged 18 to 60 years with body mass index (BMI) of 27 to 46 kg/m2. The IMF group was instructed to restrict energy intake by 80% on 3 nonconsecutive days per week, with ad libitum intake (no restriction) the other 4 days (4:3 IMF). The DCR group was instructed to reduce daily energy intake by 34% to match the weekly energy deficit of 4:3 IMF. Both groups received a high-intensity comprehensive behavioral weight loss program that included group-based behavioral support and a recommendation to increase moderate-intensity physical activity to 300 minutes per week. The primary outcome was change in body weight (in kilograms) at 12 months. Of the 165 (4:3 IMF, n = 84; DCR, n = 81) randomly assigned participants (mean age, 42 years [SD, 9]; mean BMI, 34.1 kg/m2 [SD, 4.4]; 73.9% female), 125 completed the trial. In an intention-to-treat analysis, 4:3 IMF showed greater reductions in weight than DCR at 12 months (mean difference, 2.89 kg [95% CI, 5.65 to 0.14 kg]; P = 0.040). Limited generalizability. Compared with DCR, 4:3 IMF resulted in modestly greater weight loss among adults with overweight or obesity enrolled in a 12-month, high-intensity, comprehensive behavioral weight loss program. National Institute of Diabetes and Digestive and Kidney Diseases.

12 April 2022 in Obesity
Verified
Journal Article
Open access
PDF file
AZAdnin Zaman
Adnin Zaman
KSKelsey Jones Sloggett
Kelsey Jones Sloggett
ACAnn E. E Caldwell
Ann E. E Caldwell
VCVictoria A. Catenacci
Victoria A. Catenacci
MCMarc‐Andre Cornier
Marc‐Andre Cornier
ETElizabeth A Thomas
Elizabeth A Thomas
Objective: This study aimed to assess the effects of the COVID‐19 pandemic on weight loss, physical activity, and sleep in adults with overweight or obesity participating in a 39‐week weight‐loss intervention.Methods: Participants (n = 81, 85% female, mean [SD] age 38.0 [7.8] years, BMI 34.1 [5.7] kg/m2) were enrolled in 3 separate cohorts. Cohorts 1 and 2 were studied prior to the pandemic (pre‐COVID cohorts). Cohort 3 (COVID cohort) transitioned to a virtual intervention at week 6, when “stay‐at‐home” orders were implemented in Colorado. Weight was assessed at baseline, week 12, and week 39 with clinic scales before the pandemic and home scales during the pandemic. Diet was assessed with Likert scales at weeks 4, 8, and 12. Physical activity and sleep were assessed at baseline and week 12 with actigraphy.Results: Participants in the COVID cohort reported greater dietary adherence (p = 0.004) and lost more weight than those in the pre‐COVID cohorts at week 12 (−7.7 [3.3] kg vs. −3.7 [3.0] kg, p < 0.001) and week 39 (−8.5 [4.4] kg vs. −2.8 [4.6] kg, p < 0.001). Energy intake did not differ between cohorts (p = 0.51). The COVID cohort increased both sedentary time while awake and time in bed at night.Conclusions: Although the pandemic caused disruptions for the COVID cohort, participants still achieved weight loss with continued behavioral support.

1 October 1993 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
MMM J Moore
M J Moore
CEC Erlichman
C Erlichman
LGLaura Grau
Laura Grau
SFS Fine
S Fine
Increased activity against colorectal cancer by 5-fluorouracil (5-Fu) modulation with leucovorin (LV) and/or interferon (IFN) has been reported. In this study 22 patients with measurable advanced pancreatic cancer received 5-Fu 375 mg/m2 and LV 20 mg/m2 by i.v. bolus daily x 5 every 28 days plus IFN-alpha 3 million units/m2 s.c. There were three out of 21 (14%) responses lasting from 4 to 8 months. Sixteen patients (73%) had one or more episodes of grade 3 or greater toxicity (stomatitis, diarrhea or fatigue). While this combination has some activity against pancreatic cancer, its toxicity limits its potential as a palliative treatment.

19 February 2026 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
DTDarcy Thompson
Darcy Thompson
LGLaura Grau
Laura Grau
SSSarah Schmiege
Sarah Schmiege
NCNatasha J Cabrera
Natasha J Cabrera
LCLauren Clark
Lauren Clark
JTJeanne M Tschann
Jeanne M Tschann
Background: Parents, as the most proximal influence on young children, play an important role in shaping toddler behaviors. Yet, evidence on how parents shape toddler screen use is limited. Little is also known about the relationship between toddler screen use and BMI. Given existing disparities in screen use and early childhood obesity, a focus on Mexican American families with toddlers is warranted. Objective: This study aimed to evaluate the independent contributions of both maternal screen use and screen-related parenting practices with toddler screen use duration, for both TV viewing and mobile device use, and examine the relationship between toddler screen use duration and BMI. Methods: This cross-sectional study enrolled 384 Mexican American mother-toddler dyads recruited from safety net clinics. Enrolled mothers completed 7-day screen use diaries and surveys on screen-related parenting practices, and toddler anthropometrics were obtained. Negative binomial regression models estimated the relationships between screen-related parenting practices and maternal screen use (predictors) with child duration of daily TV use and mobile device use (outcomes). Spearman correlations were calculated to estimate the relationship between toddler screen use duration and age- and sex-specific BMI z scores. Results: Maternal duration of daily TV and mobile device use were associated with toddler duration of daily TV (adjusted rate ratios [aRRs] 1.27‐1.28; all P <.001) and mobile device use (aRRs 1.17‐1.18; all P <.001), respectively, even after adjusting for maternal screen-related parenting practices. Specific parenting practices, including restriction of TV time (aRR=0.86; P =.01), restriction of mobile device time (aRR=0.80; P =.02), use of TV (aRR=1.27; P =.003) and mobile devices (aRR=1.78; P <.001) for child behavior regulation, and coviewing of mobile devices (aRR=1.51; P <.001), were associated with toddler duration of daily screen use, adjusted for maternal duration of daily screen use. Neither toddler duration of daily TV viewing nor daily mobile device use was correlated with toddler BMI z scores . Conclusions: Both the duration of maternal screen use and screen-related parenting practices, for both TV and mobile devices, should be considered when promoting healthy screen use in toddlers in Mexican American families. Interventionists should consider the family ecology when designing interventions promoting healthy screen use in early childhood.

17 April 2026 in Journal of Nutrition Education and Behavior
Verified
Journal Article
Closed access
DTDarcy Thompson
Darcy Thompson
LGLaura Grau
Laura Grau
SSSarah J. Schmiege
Sarah J. Schmiege
NCNatasha J. Cabrera
Natasha J. Cabrera
LCLauren Clark
Lauren Clark
JTJeanne M. Tschann
Jeanne M. Tschann